P

Protara Therapeutics

Clinical-stage biopharma developing cancer therapies

Clinical Project Manager - Temp to Perm

Clinical Research OperationsConfirmed live in the last 24 hours
ContractNew York, NY, USA$68 - $78 /hr

About the Job

Requirements

  • A bachelor's degree in clinical research, life science, or a related field is required.
  • At least 5 years of relevant clinical trial management experience in the pharmaceutical or biotechnology industry is required.
  • Knowledge of International Council for Harmonisation (ICH), Good Clinical Practice (GCP), and Code of Federal Regulations (CFR) guidelines.
  • Prior experience with different electronic data capture (EDC) platforms.
  • Proficiency in Microsoft Office Suite.
  • Knowledge of the clinical trial monitoring process.
  • Strong ability to prioritize tasks with keen attention to detail.
  • Strong organizational, analytical, and problem-solving skills.
  • Must be a dependable self-starter who can work independently, prioritize tasks, and meet deadlines.
  • Ability to thrive in a small, fast-paced biotechnology environment.
  • Strong interpersonal skills and ability to interact effectively with all levels of internal and external management.
  • Willingness to travel to clinical research sites, vendors, and the New York City office as needed.

Responsibilities

  • Serve as the secondary clinical operations contact for one or more clinical trials, as needed.
  • Liaise with other functions to provide study-specific information for regulatory submissions and safety reporting, including Development Safety Update Report submissions to Institutional Review Boards and Safety Vigilance portal access.
  • Work with cross-functional team members during the study conduct phase.
  • Review bid-defense proposals; assist in contract research organization (CRO) selection, letters of intent, statements of work, budget reviews, and timeline development.
  • Support vendor selection, onboarding, and management throughout the study lifecycle.
  • Manage the study-specific electronic trial master file (eTMF) and related activities to ensure inspection readiness compliance.
  • Assist with management of clinical trial finances, including verifying CRO invoices against fully executed contracts, reviewing monthly work-completed workbooks, and reviewing site budgets and invoices.
  • Interact with CROs, clinical trial sites, investigators, study coordinators, pharmacists, and company personnel as appropriate.
  • Serve as a resource for internal and external teams and investigational sites.
  • Remotely monitor electronic data capture (EDC) data on a predetermined basis for expected interim data cuts.
  • Review clinical protocols, amendments, informed consents, case report form and source document design, monitoring plans, site instruction manuals, protocol-specific training documentation, oversight plans, and other project-related documents, as applicable.
  • Assist with identification, selection, activation, and participation of global clinical trial sites.
  • Assist with reviewing pre-study site, site initiation, interim, and close-out visit reports within specified time frames, as applicable.
  • Oversee tracking of study recruitment and enrollment, trial-specific reports, and documents required for clinical trial completion.
  • Perform internal oversight of clinical trial managers and clinical research associates conducting site monitoring visits.
  • Serve as the primary point of contact for internal clinical trial managers and clinical research associates.
  • Proactively manage and identify potential study issues and risks, and recommend and implement solutions with key internal and external stakeholders.
  • Prepare metrics and updates for senior management.
  • Mentor junior staff and perform additional duties or functions as required.
  • Contribute to wider organizational goals and activities as assigned.
  • Travel to clinical research sites to conduct CRO clinical monitoring oversight as needed.

Desired Qualifications

  • Knowledge of Smartsheet.

About the Company

Protara Therapeutics

Clinical-stage biopharma developing cancer therapies

Protara Therapeutics operates as a clinical-stage biopharmaceutical company focused on therapies for cancer and rare diseases, funded by public markets with a cash runway into 2027. Lead asset TARA-002 is an immunopotentiator cell therapy derived from Streptococcus pyogenes, designed to stimulate innate and adaptive immunity in tumors, with NMIBC trials showing promising responses. A second asset, IV Choline Chloride, provides intravenous choline for IFALD in parenteral nutrition-dependent patients, aiming to be the first approved therapy and holding FDA orphan drug and fast track designations. The company distinguishes itself by pursuing late-stage assets with clear regulatory and commercialization paths, backed by leadership with biopharma and finance experience, aiming to obtain regulatory approvals and bring therapies to patients with significant unmet needs.

Company size
51-200
Company stage
IPO
Headquarters
New York City, United States
Founded
2006

Recently Posted Jobs

Explore more opportunities at Protara Therapeutics

See more jobs